F-M Habana Hospital performs the first Regeneten implant in Spain and continental Europe
Approximately a month ago, the first Regeneten implant was performed for the first time in Spain for the treatment of a recurrence of a supraspinatus tendon rupture, operated on 9 months ago with a simple row technique. It has been used as a biological augmentation, after a new double-row Speedbridge repair.
One of the pathologies most treated in the Hospital, almost 80 percent, is shoulder disease, especially the rotator cuff, specifically with ruptures of either the supraspinatus or infraspinatus tendons. These tendons often break due to overuse, not due to trauma, but because something affects a tendon that is already previously damaged and injured, then that causes it to break. And that same reason adds difficulty to the treatment and healing.
Currently these injuries are treated with good results by arthroscopy, making very solid constructions, but the biological part, that is, the part that makes the tendon heal, is not yet completely resolved. Many treatments have been tried, platelet-rich plasma does not seem to have a decisive influence on the tendon and what has been carried out in a pioneering way at the Fraternidad-Muprespa Havana Hospital, is a patch of bovine collagen, which acts as if it were a scaffolding, into which cells penetrate that help to reestablish the structural integrity of the tendon.
These patches are placed on tendons that have been repaired, that are still damaged and are not in very good health, so that regardless of the mechanical part, which is what is normally done through sutures, it is complemented with something biological, that is, that the cells can grow and heal that tendon more easily.
This bovine collagen patch is very thin, bioinductive (it does not have any type of mechanical resistance) and will be used in those cases of reinterventions for sutures that have previously failed and in tendons in very poor condition.
The patch comes pre-assembled on a device that deploys it and attaches it to the tendon with resorbable, biocompatible, polylactic and polyether ether ketone (PEEK) material.
The head of the Traumatology service, the members of the Shoulder and Elbow unit, as well as the staff of the surgical block participated in the intervention, helping to make the work of this new technique easier.
We have been the first to use this patch in Spain and in Continental Europe, one has been made in the United Kingdom and in the US it has already been carried out in more cases, because it is also used there in other types of ruptures, partial articular tendon tears.
In addition, a pilot program is open in which statistics and experiences from four European countries Germany, France, Italy and Spain will be exchanged, with a common registry for patients operated on with this technique and to be able to draw conclusions from its operation and the Fraternidad-Muprespa Havana Hospital will contribute the results obtained from this innovative technique.
